Expertise you can trust.
Navigating regulatory processes can be a daunting task for Emerging Biopharma companies striving to advance cutting-edge technologies and groundbreaking products. Drawing upon over 45 years of collective expertise in regulated industries, we possess a profound understanding of the intricate regulatory landscape. We are adept at addressing your challenges head-on, offering comprehensive services that focus on guiding you through the clinical stages of product development.
Our globally operating team is renowned for crafting effective regulatory strategies that elevate our clients’ success rates and expedite the journey of innovative products to market. We specialize in providing strategic counsel tailored to Emerging Biopharma companies in key regions such as the US, EU, UK, Switzerland, and Canada.
At Senita, client education is paramount. We prioritize equipping our clients with insights into regulatory decisions and requirements pertinent to their areas of expertise. Our bespoke approach is geared towards developing optimal regulatory roadmaps for each client's unique product, ensuring alignment with global regulations. To stay abreast of pivotal regulatory developments, we maintain close ties with esteemed organizations like the Regulatory Affairs Professional Society (RAPS) and academic institutions such as the University of Southern California (USC).
Therapeutic Areas
-
As a leading cause of mortality globally, cardiovascular diseases (CVDs) demand innovative solutions. At Senita, we understand the importance of bringing cardiovascular therapies to market quickly and efficiently. We specialize in navigating regulatory submissions for cardiovascular products for the treatment of heart failure, coagulation disorders, and arrhythmia, helping you save more lives.
If you are in the clinical stages of developing products for cardiovascular conditions, our tailored regulatory strategies and deep therapeutic expertise can help you succeed.
-
Dermatological conditions are the fourth leading cause of global disability, resulting in a poor quality of life for patients. There is a growing need for innovative treatments that can improve outcomes.
At Senita, we are dedicated to helping you navigate the complexities of regulatory submissions for the clinical stages of dermatological product development. We understand the unique challenges facing this therapeutic area and can provide tailored guidance on regulatory strategies to meet your next inflection point, and to bring your product to market more efficiently.
-
Endocrine and metabolic diseases are complex conditions that require innovative therapies. At Senita, we understand the challenges of navigating regulatory submissions for these products and can provide comprehensive regulatory support to help you achieve success.
We have deep therapeutic expertise in areas such as lysosomal storage diseases and cystic fibrosis. We provide tailored guidance on regulatory strategies focusing on the clinical stages of endocrinology and metabolic product development.
-
Gastrointestinal diseases can significantly impact patients' quality of life and require innovative therapies to improve outcomes. At Senita, we understand the complexities of regulatory submissions for gastroenterological products and can provide comprehensive regulatory support to help you bring your product to market more efficiently.
We have deep therapeutic expertise in this area and can provide tailored guidance on regulatory strategies focusing on the clinical stages of the development of gastroenterology products, including inflammatory bowel diseases and non-alcoholic steatohepatitis (NASH).
-
Blood disorders and hematological malignancies require innovative therapies to improve outcomes for patients. At Senita, we are dedicated to helping you navigate the complexities of regulatory submissions for the clinical stages of hematological product development.
We have deep therapeutic expertise in this area, including both malignant and non-malignant hematological disorders, and can provide tailored guidance on regulatory strategies to bring your product to market more efficiently.
-
The immune system plays a critical role in health and disease, and there is a growing need for innovative immunological therapies. Since 2000, a significant increase in immunologic and inflammatory disorders has been observed globally. At Senita, we understand the complexities of navigating regulatory submissions for immunological products and can provide comprehensive regulatory support focusing on the clinical stages of immunology product development.
We have deep therapeutic expertise in this area and can provide tailored guidance on regulatory strategies to bring your product to market more efficiently.
-
Neurological and central nervous system (CNS) disorders are complex conditions requiring innovative therapies to improve patient outcomes. At Senita, we understand the unique challenges facing this therapeutic area and are dedicated to helping you navigate regulatory submissions for neurological and CNS products.
We have deep therapeutic expertise in this area and can provide tailored guidance on regulatory strategies focusing on the clinical stages of neurology product development.
-
Cancer is the second leading cause of mortality globally. It is a complex disease requiring innovative therapies to improve patient outcomes. At Senita, we are dedicated to helping you navigate regulatory submissions for oncological products.
We have deep therapeutic expertise covering both solid and hematological malignancies. We provide tailored guidance on regulatory strategies focusing on the clinical stages of oncology product development to help you make a difference in the lives of cancer patients.
-
Eye diseases and conditions can significantly impact patients' quality of life and require innovative therapies to improve outcomes.
At Senita, we understand the complexities of navigating regulatory submissions for ophthalmological products for both back and front of the eye applications. We provide comprehensive regulatory support focusing on the clinical stages of ophthalmology product development to help you achieve success.
-
Pediatric products require a unique approach to regulatory strategy due to the specific needs of the pediatric population. At Senita, we understand the importance of pediatric therapies and the challenges in their development.
We have a wealth of experience navigating the regulatory landscape for pediatric products and provide comprehensive services focusing on the clinical stages of pediatric product development. We help you navigate regulatory requirements and submissions for pediatric products so that you can bring innovative therapies to children in need.
-
It is estimated that more than 970 million people worldwide live with a psychiatric disorder. Psychiatric disorders can have a significant impact on patients’ lives. At Senita, we understand the importance of developing effective therapies for psychiatric disorders.
We have substantial experience navigating the complex regulatory landscape for psychiatric products. We offer comprehensive services focusing on the clinical stages of product development for psychiatric disorders. We help you navigate regulatory submissions for psychiatric products so that you can bring innovative therapies to patients with unmet needs.
-
Respiratory diseases can be debilitating and life-threatening. Just in the United States over 25 million people have asthma. At Senita, we understand the importance of developing effective therapies for respiratory diseases.
We have extensive experience navigating the complex and interdisciplinary regulatory landscape for respiratory products. We offer comprehensive services focusing on the clinical stages of product development for respiratory diseases. We help you navigate regulatory submissions for respiratory products so that you can bring innovative therapies to patients in need.
-
Individually, most rare diseases might affect only a few hundred to a few thousand people worldwide. However, rare diseases are collectively common, affecting an estimated 25 million to 30 million people just in the United States. At Senita, we understand the challenges in developing therapies for rare diseases.
We have significant experience navigating the unique regulatory landscape for rare diseases and orphan-designated products. We provide comprehensive services that focus on the clinical stages of product development for rare diseases. We help you navigate regulatory submissions for rare disease products so that you can bring innovative therapies to patients with unmet needs.
-
Rheumatologic disorders can significantly impact patients’ quality of life. At Senita, we understand the importance of developing effective therapies for rheumatologic conditions, such as arthritis, vasculitis, autoimmune connective tissue diseases, and inflammatory muscle diseases.
We have extensive experience navigating the complex regulatory landscape for rheumatology products. We offer comprehensive services focusing on the clinical stages of product development for rheumatologic disorders. We help you navigate regulatory requirements and submissions for rheumatology products so that you can bring innovative therapies to patients with unmet needs.
Product Types
-
Navigating regulatory submissions for small molecule products can be a complex process. At Senita, we have over two decades of experience in regulatory compliance and product development for small molecules.
We offer comprehensive services to support the clinical stages of development. Our team can help you navigate the regulatory landscape and optimize your product development process to bring innovative small molecule products to market faster.
-
As one of the most promising areas of biopharmaceutical research, gene therapy holds enormous potential for treating various genetic diseases. However, navigating the regulatory landscape for gene therapy products can be challenging.
At Senita, we specialize in providing regulatory guidance and support for gene therapy and other advanced therapy products. We work closely with our clients to develop customized regulatory strategies that maximize the potential for success in product development and regulatory submissions.
-
Cell therapy products are a rapidly growing area of biopharmaceutical research, with enormous potential to revolutionize the treatment of a wide range of diseases. However, the regulatory requirements for cell therapy products can be complex and challenging to navigate, as the patient, product, and supply chain requires specialized sets of capabilities, as standards and protocols differ from more traditional therapy areas.
At Senita, we specialize in providing regulatory guidance and support for cell therapy products with expertise across major geographies.
-
Monoclonal antibodies (mAbs) are an established therapeutic modality, with an enormous range of targets across various disease areas. However, navigating the regulatory landscape for mAb products can be challenging.
We have years of experience in regulatory compliance and product development for mAb products. With our expertise in mAbs, we can help you navigate the complex regulatory landscape and bring innovative mAb products to market faster.
-
Oligonucleotide products are a rapidly growing area of biopharmaceutical research, with enormous potential to treat various diseases and over 120 active development programs worldwide.
We have significant experience in regulatory compliance and product development for oligonucleotide products. We can help you navigate the regulatory landscape and optimize your product development process to reach your next inflection point and to design a successful regulatory strategy.
-
RNA therapeutics is a rapidly growing area of biopharmaceutical research with enormous potential to treat many diseases with targets considered hitherto “undruggable”. However, navigating the regulatory landscape for RNA therapeutic products can be complex and challenging.
We specialize in providing regulatory guidance and support for RNA therapeutic products. We can help you navigate the regulatory landscape and optimize your product development process to bring innovative RNA therapeutic products to market faster.
-
Cancer vaccines are a rapidly growing area of biopharmaceutical research, with enormous potential to treat many cancers. They represent an exciting development in cancer immunotherapy, with the goal of creating and amplifying tumor-specific T-cell responses.
At Senita, we specialize in providing regulatory guidance and support for therapeutic cancer vaccines in the clinical stages of development. We stay current with the latest regulatory developments in curative cancer vaccines, helping you navigate complex regulatory requirements and develop a strategic approach to your development program.
-
Nanomaterials have opened new possibilities for drug delivery and medical devices, but the regulatory landscape for these products can be complex.
We have extensive experience in the regulatory environment for nanosized delivery systems, enabling us to provide our clients with a comprehensive understanding of the regulatory challenges surrounding nanomaterials. We are dedicated to helping our clients bring their innovative nanomaterial-based products to market quickly and efficiently.
-
Glycomimetics is a growing area of research and development in the biopharmaceutical industry. These compounds can potentially treat a broad variety of neoplastic, inflammatory, and metabolic diseases, but the regulatory requirements for glycomimetics can be challenging to navigate.
Our team understands the regulatory landscape surrounding glycomimetics, and we work closely with our clients to ensure that their products meet all regulatory requirements. We are dedicated to helping our clients bring their innovative glycomimetics products to market quickly and efficiently.
-
Combination products are complex products that combine drugs, devices, or biological products. The regulatory requirements for these products can be challenging, as they require expertise in numerous areas and compliance across regulatory domains.
At Senita, we understand the regulatory landscape surrounding combination products, and we work closely with our clients to ensure that their products meet all regulatory requirements. We are dedicated to helping our clients bring their innovative combination products to market quickly and efficiently.
